FDA Drug Application (017426) for DESONIDE by PERRIGO NEW YORK

Back to FDA Applications sponsored by PERRIGO NEW YORK

Application Number017426
Product Number001
FormOINTMENT;TOPICAL
Dosage0.05%
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameDESONIDE
Active IngredientDESONIDE

Active IngredientCount
List of drugs with Active Ingredient DESONIDE5


Back to FDA Applications sponsored by PERRIGO NEW YORK